VAS
CRL icon

Vestmark Advisory Solutions’s Charles River Laboratories CRL Stock Holding History

Vestmark Advisory Solutions’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
4,561
+1,031
+29% +$184K 0.01% 948
2026
Q1 		$609K Sell
3,530
-144
-4% -$26.7K 0.01% 1005
2025
Q4 		$733K Buy
+3,674
New +$666K 0.01% 896
2025
Q2 		– Sell
-41,820
Closed -$6.29M – 782
2025
Q1 		$6.29M Buy
41,820
+18,252
+77% +$3.06M 0.16% 165
2024
Q4 		$4.35M Sell
23,568
-2,196
-9% -$423K 0.15% 148
2024
Q3 		$5.07M Buy
25,764
+2,219
+9% +$461K 0.19% 110
2024
Q2 		$4.86M Buy
23,545
+4,086
+21% +$926K 0.2% 108
2024
Q1 		$5.27M Buy
19,459
+1,339
+7% +$320K 0.23% 105
2023
Q4 		$4.28M Buy
18,120
+1,231
+7% +$242K 0.22% 116
2023
Q3 		$3.31M Sell
16,889
-21,481
-56% -$4.41M 0.24% 98
2023
Q2 		$8.07M Buy
38,370
+1,434
+4% +$285K 0.31% 77
2023
Q1 		$7.45M Buy
36,936
+1,561
+4% +$354K 0.32% 67
2022
Q4 		$7.71M Sell
35,375
-795
-2% -$174K 0.38% 51
2022
Q3 		$7.12M Buy
36,170
+2,734
+8% +$590K 0.4% 45
2022
Q2 		$7.15M Buy
33,436
+4,209
+14% +$1.03M 0.41% 43
2022
Q1 		$8.3M Buy
29,227
+3,815
+15% +$1.18M 0.47% 32
2021
Q4 		$9.57M Buy
25,412
+3,299
+15% +$1.28M 0.54% 28
2021
Q3 		$9.13M Buy
22,113
+2,190
+11% +$910K 0.62% 23
2021
Q2 		$7.37M Buy
19,923
+1,868
+10% +$624K 0.52% 30
2021
Q1 		$5.23M Buy
18,055
+6,376
+55% +$1.77M 0.46% 34
2020
Q4 		$2.92M Buy
11,679
+966
+9% +$230K 0.33% 73
2020
Q3 		$2.43M Buy
10,713
+1,330
+14% +$276K 0.33% 78
2020
Q2 		$1.64M Buy
9,383
+756
+9% +$121K 0.25% 120
2020
Q1 		$1.09M Buy
+8,627
New +$1.29M 0.21% 150
2019
Q4 		– Sell
-7,567
Closed -$1M – 313
2019
Q3 		$1M Buy
7,567
+2,582
+52% +$346K 0.16% 184
2019
Q2 		$707K Buy
4,985
+319
+7% +$43.3K 0.12% 224
2019
Q1 		$678K Buy
+4,666
New +$613K 0.12% 231

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vestmark Advisory Solutions's CRL Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Charles River Laboratories (CRL) stake by 29% in Q2 2026, buying an estimated $184K and bringing the position to 4,561 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #948.

Vestmark Advisory Solutions first reported a position in CRL in Q1 2019 and has held it in 27 quarters since. The position peaked at $9.57M in Q4 2021. 565 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Vestmark Advisory Solutions held 4,561 shares of Charles River Laboratories worth $1.03M as of Q2 2026.
  • Vestmark Advisory Solutions bought 1,031 Charles River Laboratories shares in Q2 2026, an estimated $184K.
  • Charles River Laboratories made up 0.01% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #948 holding.
  • Vestmark Advisory Solutions first reported a position in Charles River Laboratories in Q1 2019 and has held it in 27 quarters since.
  • Vestmark Advisory Solutions's Charles River Laboratories position peaked at $9.57M in Q4 2021.
  • 565 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.